"How long will I need to be on this?" is one of the most common questions we hear from patients starting buprenorphine treatment. It's a completely understandable question — many people start treatment hoping to eventually be "done" with medication altogether, the same way you might finish a course of antibiotics. But opioid use disorder isn't treated like a short-term infection, and buprenorphine doesn't work like a course of antibiotics either. Understanding why can help take the pressure off finding the "right" stopping point and let you focus instead on what's actually working for you.
Why There's No Fixed Time Limit
The American Society of Addiction Medicine (ASAM), the leading professional body for addiction medicine in the United States, is direct about this in its National Practice Guideline: there is no recommended time limit for pharmacological treatment with buprenorphine. This is a meaningful departure from the older, more familiar idea of "detox" — a short, defined period of medication used just to get through withdrawal. Buprenorphine maintenance treatment is designed differently. It works by stabilizing brain chemistry over an extended period, which is part of why arbitrarily capping treatment at a set number of weeks or months isn't supported by the evidence.
ASAM's National Practice Guideline states plainly that "there is no recommended time limit for pharmacological treatment with buprenorphine." The guideline also notes that when a taper is appropriate, it is a gradual process, generally carried out over several months rather than weeks — underscoring that both staying on treatment and coming off it are meant to happen on a timeline suited to the individual patient, not a fixed calendar.
What the Research Says About Treatment Duration
The Substance Abuse and Mental Health Services Administration (SAMHSA) reaches a similar conclusion in its clinical guidance for medications for opioid use disorder (TIP 63): arbitrary time limits on medication treatment are discouraged, and the best outcomes tend to occur when a patient stays on medication for as long as it continues to provide benefit. That's a very different framework than "treatment for X months, then stop" — it puts the emphasis on how you're doing, not on the calendar.
Research on treatment retention backs this up in a related way. A large cohort study of over 6,400 Rhode Island patients starting buprenorphine between 2016 and 2020, highlighted in a National Institute on Drug Abuse (NIDA) news release, found that a substantial share of patients discontinued treatment early: 59% of patients on the standard 16 mg/day dose had stopped treatment by 180 days, compared to 53% of those on a higher 24 mg/day dose. The point here isn't the specific dose — that's a decision for you and your provider — it's that early discontinuation is common, and staying engaged in adequately dosed treatment for longer is linked to better retention. In other words, leaving treatment prematurely is a bigger risk in practice than staying on it "too long."
SAMHSA's TIP 63 guidance advises against imposing arbitrary time limits on medication treatment for opioid use disorder, noting that the best results occur when a patient receives medication for as long as it continues to provide a benefit — not according to a predetermined schedule.
Signs You Might Be Ready to Discuss Tapering
There isn't a checklist patients can use to self-diagnose readiness to taper, and we'd caution against trying to build one — this is a clinical decision that should always be made collaboratively, over time, with your provider. That said, providers generally weigh a combination of factors when this conversation comes up: a sustained period of stability without cravings or return to use, strong recovery supports in your life (relationships, housing, work, counseling or peer support if you're using them), and your own sense of readiness and motivation. None of these factors on their own means it's time to taper, and having some of them doesn't mean you're "behind" if you're not there yet. If you're curious about tapering, the right move is to bring it up at an upcoming visit so we can look at the full picture together, not to decide on your own that a certain amount of time means you should be finished.
Long-Term Maintenance Is a Valid Choice
For many patients, staying on buprenorphine indefinitely is the right, evidence-based choice — not a fallback or a sign that something didn't work. It's helpful to think of it the way you would a medication for any other chronic condition: someone with hypertension or diabetes who stays on their medication for years isn't failing to "graduate" from treatment, they're managing a chronic condition effectively. Opioid use disorder is increasingly understood the same way. There is no universal "should" here — some patients taper successfully after a year or two, and some stay on buprenorphine for many years or indefinitely, and both are legitimate, successful outcomes. What matters is that the decision fits your health, your history, and your life, and that it's made with your provider rather than against an arbitrary clock.
This article is for general educational purposes and isn't a substitute for individualized medical advice. Your treatment plan should be developed with your own provider based on your specific health history.
Whether you're just starting or need an ongoing refill, our online Suboxone treatment in California page explains what a typical visit looks like and how to get connected with a provider.